Go Pro

NewHold Investment Corp. II (NHICU) Financials

$11.89 0.00 (0.00%)
As of 08/14/2026 09:30 AM Eastern
Annual Income Statements for NewHold Investment Corp. II

Annual Income Statements for NewHold Investment Corp. II

This table shows NewHold Investment Corp. II's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-27 -11 -87 -108 -54 -33
Consolidated Net Income / (Loss)
-27 -11 -87 -108 -54 -33
Net Income / (Loss) Continuing Operations
-27 -11 -87 -108 -54 -33
Total Pre-Tax Income
-27 -11 -87 -108 -54 -33
Total Operating Income
-27 -55 -103 -90 -82 -48
Total Gross Profit
1.29 4.03 1.40 32 59 75
Total Revenue
4.79 23 53 80 104 146
Operating Revenue
4.79 23 53 80 104 146
Total Cost of Revenue
3.50 19 51 48 44 71
Total Operating Expenses
28 59 104 122 142 124
Selling, General & Admin Expense
5.11 20 38 42 57 55
Marketing Expense
7.37 26 47 55 61 46
Research & Development Expense
16 11 19 24 23 21
Impairment Charge
0.00 1.87 1.16 0.32 0.22 0.00
Restructuring Charge
- - - - 0.86 2.66
Total Other Income / (Expense), net
-0.50 44 16 -18 28 15
Interest Expense
0.50 19 0.71 1.28 0.00 1.73
Interest & Investment Income
- 0.00 3.17 6.23 2.94 1.54
Other Income / (Expense), net
0.00 63 14 -23 25 16
Income Tax Expense
- - 0.00 0.05 0.00 0.06
Basic Earnings per Share
($3.07) ($0.15) ($0.60) ($0.72) ($0.34) ($0.20)
Weighted Average Basic Shares Outstanding
8.93M 71.66M 143.86M 149.17M 156.57M 168.42M
Diluted Earnings per Share
($3.07) ($0.15) ($0.60) ($0.72) ($0.34) ($0.20)
Weighted Average Diluted Shares Outstanding
8.93M 71.66M 143.86M 149.17M 156.57M 168.42M
Weighted Average Basic & Diluted Shares Outstanding
- 143.30M 147.96M 152.18M - 179.35M

Quarterly Income Statements for NewHold Investment Corp. II

This table shows NewHold Investment Corp. II's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-17 -11 3.38 -30 -16 -1.69 -41 -1.80 11 -5.01 -9.30
Consolidated Net Income / (Loss)
-17 -11 3.42 -30 -16 -1.69 -41 -1.80 11 -5.01 -9.30
Net Income / (Loss) Continuing Operations
-17 -11 3.42 -30 -16 -1.69 -41 -1.80 11 -5.01 -9.30
Total Pre-Tax Income
-17 -11 3.42 -30 -16 -1.63 -41 -1.80 11 -5.05 -9.30
Total Operating Income
-22 -22 -22 -19 -19 -14 -17 -8.60 -7.99 -8.47 -11
Total Gross Profit
10 12 15 16 17 19 16 21 19 24 22
Total Revenue
22 22 25 27 29 32 33 43 39 46 44
Operating Revenue
22 22 25 27 29 32 33 43 39 46 44
Total Cost of Revenue
12 10 10 12 12 13 16 22 20 23 22
Total Operating Expenses
32 34 37 35 36 34 34 30 27 32 33
Selling, General & Admin Expense
11 12 14 14 17 15 17 13 10 14 14
Marketing Expense
15 16 16 15 13 11 12 12 11 13 13
Research & Development Expense
6.26 6.40 5.85 5.81 5.39 4.86 4.74 5.61 5.41 5.89 5.78
Restructuring Charge
- 0.00 0.86 0.00 - 2.66 0.00 0.00 - 0.00 0.00
Total Other Income / (Expense), net
5.07 11 26 -11 3.16 13 -23 6.80 19 3.43 1.25
Interest Expense
- 0.00 0.00 0.00 - 0.00 0.00 0.71 1.02 0.96 0.97
Interest & Investment Income
1.63 1.09 0.68 0.63 0.55 0.39 0.22 0.44 0.49 0.52 0.49
Other Income / (Expense), net
3.44 9.55 25 -12 2.61 12 -23 7.08 19 3.87 1.73
Income Tax Expense
- 0.00 0.00 0.00 - 0.06 -0.00 0.00 - -0.04 0.00
Basic Earnings per Share
($0.10) ($0.07) $0.02 ($0.19) ($0.10) ($0.01) ($0.25) ($0.01) $0.07 ($0.03) ($0.05)
Weighted Average Basic Shares Outstanding
149.17M 153.08M 156.47M 157.71M 156.57M 160.81M 165.25M 172.79M 168.42M 177.06M 180.10M
Diluted Earnings per Share
($0.09) ($0.07) $0.02 ($0.19) ($0.10) ($0.01) ($0.25) ($0.01) $0.07 ($0.03) ($0.05)
Weighted Average Diluted Shares Outstanding
149.17M 153.08M 171.56M 157.71M 156.57M 160.81M 165.25M 172.79M 168.42M 177.06M 180.10M
Weighted Average Basic & Diluted Shares Outstanding
152.18M 156.09M 157.55M - 0.00 164.00M 171.89M 174.62M 179.35M 179.87M 181.13M

Annual Cash Flow Statements for NewHold Investment Corp. II

This table details how cash moves in and out of NewHold Investment Corp. II's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-13 303 -78 -163 -30 12
Net Cash From Operating Activities
-23 -57 -75 -9.80 -31 19
Net Cash From Continuing Operating Activities
-23 -57 -75 -9.80 -31 19
Net Income / (Loss) Continuing Operations
-27 -11 -87 -108 -54 -33
Consolidated Net Income / (Loss)
-27 -11 -87 -108 -54 -33
Depreciation Expense
1.07 2.90 5.44 9.70 17 24
Amortization Expense
- - 0.00 -0.58 0.45 -0.13
Non-Cash Adjustments To Reconcile Net Income
0.79 -38 13 51 5.59 15
Changes in Operating Assets and Liabilities, net
2.29 -11 -6.41 38 -0.25 13
Net Cash From Investing Activities
-6.61 -18 -24 -123 -1.40 -42
Net Cash From Continuing Investing Activities
-6.61 -18 -24 -123 -1.40 -42
Purchase of Property, Plant & Equipment
-6.61 -18 -24 -73 -37 -37
Purchase of Investments
- - 0.00 -90 -29 -39
Sale and/or Maturity of Investments
- - 0.00 39 65 35
Net Cash From Financing Activities
17 378 21 -30 1.81 35
Net Cash From Continuing Financing Activities
17 378 21 -30 1.81 35
Issuance of Debt
22 32 30 1.88 0.00 26
Other Financing Activities, net
0.44 86 0.83 0.67 1.81 9.09
Effect of Exchange Rate Changes
- 0.00 -0.01 -0.04 0.02 -0.11
Cash Interest Paid
0.41 0.85 0.58 0.71 0.00 1.25

Quarterly Cash Flow Statements for NewHold Investment Corp. II

This table details how cash moves in and out of NewHold Investment Corp. II's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-33 -23 -8.90 10 -9.29 -12 12 -5.44 18 6.93 -2.65
Net Cash From Operating Activities
-3.14 -16 -22 3.91 3.20 -2.54 2.11 3.52 16 -3.18 12
Net Cash From Continuing Operating Activities
-3.14 -16 -22 3.91 3.20 -2.54 2.11 3.52 16 -3.18 12
Net Income / (Loss) Continuing Operations
-17 -11 3.46 -30 -16 -1.69 -41 -1.80 11 -5.01 -9.30
Consolidated Net Income / (Loss)
-17 -11 3.46 -30 -16 -1.69 -41 -1.80 11 -5.01 -9.30
Depreciation Expense
3.15 3.46 3.97 4.49 5.44 5.53 5.79 6.54 6.48 6.80 7.14
Amortization Expense
-0.09 0.20 -0.02 0.08 0.19 0.07 0.06 -0.12 -0.14 0.45 0.33
Non-Cash Adjustments To Reconcile Net Income
4.92 -1.72 -15 20 1.15 -7.00 33 0.97 -12 2.04 4.54
Changes in Operating Assets and Liabilities, net
5.77 -6.82 -14 9.11 12 0.55 4.12 -2.08 10 -7.46 9.19
Net Cash From Investing Activities
-30 -6.72 13 6.00 -13 -9.36 5.75 -40 1.40 9.76 -15
Net Cash From Continuing Investing Activities
-30 -6.72 13 6.00 -13 -9.36 5.75 -40 1.40 9.76 -15
Purchase of Property, Plant & Equipment
-19 -21 -3.04 -4.72 -8.10 -14 -4.13 -15 -3.57 -4.97 -9.81
Purchase of Investments
-31 -15 - - -15 -9.88 - -25 -4.91 0.00 -9.89
Sale and/or Maturity of Investments
20 29 16 11 9.65 15 9.88 - 9.88 15 4.91
Net Cash From Financing Activities
0.05 0.30 0.33 0.52 0.66 0.02 4.08 31 0.68 0.32 0.25
Net Cash From Continuing Financing Activities
0.05 0.30 0.33 0.52 0.66 0.02 4.08 31 0.68 0.32 0.25
Other Financing Activities, net
0.05 0.30 0.33 0.52 0.66 0.02 4.08 4.31 0.68 0.32 0.25
Cash Interest Paid
- - - - - 0.00 - - 0.73 0.45 0.91

Annual Balance Sheets for NewHold Investment Corp. II

This table presents NewHold Investment Corp. II's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
22 363 344 297 268 304
Total Current Assets
9.79 331 289 173 121 151
Cash & Equivalents
4.70 307 230 67 37 49
Restricted Cash
0.00 0.40 0.00 0.28 - 0.00
Short-Term Investments
- - 0.00 51 15 20
Accounts Receivable
1.40 6.48 26 22 28 31
Inventories, net
1.59 2.89 12 10 17 9.32
Prepaid Expenses
1.54 11 15 17 18 35
Other Current Assets
0.56 3.10 5.56 5.78 6.23 6.94
Plant, Property, & Equipment, net
10 24 45 113 124 128
Total Noncurrent Assets
1.73 7.95 11 11 23 26
Other Noncurrent Operating Assets
1.73 7.95 11 11 23 26
Total Liabilities & Shareholders' Equity
22 363 344 297 268 304
Total Liabilities
31 73 118 153 150 185
Total Current Liabilities
13 24 59 81 97 123
Accounts Payable
4.44 6.05 18 17 10 9.77
Accrued Expenses
4.21 9.55 12 16 20 35
Current Deferred Revenue
3.77 6.73 18 47 65 75
Other Current Liabilities
0.00 0.00 1.11 1.39 2.20 2.99
Total Noncurrent Liabilities
17 48 39 72 54 62
Long-Term Debt
16 7.95 - - 0.00 29
Noncurrent Deferred Revenue
0.48 2.81 14 25 20 17
Other Noncurrent Operating Liabilities
0.00 38 25 47 33 17
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-8.93 290 227 144 118 119
Total Preferred & Common Equity
-85 290 227 144 118 119
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-8.93 290 227 144 118 119
Common Stock
86 396 419 445 472 507
Retained Earnings
-95 -106 -193 -301 -355 -388
Accumulated Other Comprehensive Income / (Loss)
0.00 0.00 -0.01 -0.05 -0.03 -0.14

Quarterly Balance Sheets for NewHold Investment Corp. II

This table presents NewHold Investment Corp. II's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
306 308 306 282 269 278 256 280 304 305 302
Total Current Assets
235 216 202 142 138 134 104 133 152 152 149
Cash & Equivalents
181 126 100 45 36 46 25 37 32 56 53
Restricted Cash
1.00 1.00 1.00 0.00 0.00 0.28 - - - - 0.73
Short-Term Investments
- 30 39 36 21 9.96 9.93 0.00 25 4.99 9.94
Accounts Receivable
23 32 30 22 36 35 34 42 49 43 40
Inventories, net
8.82 5.03 7.83 11 19 16 10 12 8.77 8.26 8.66
Prepaid Expenses
14 14 17 21 20 21 18 36 31 33 30
Other Current Assets
6.56 8.38 7.58 7.05 6.50 5.95 6.26 6.44 7.17 6.84 8.12
Plant, Property, & Equipment, net
60 81 94 129 120 121 130 125 127 128 129
Total Noncurrent Assets
11 11 11 10 11 23 23 22 26 25 24
Other Noncurrent Operating Assets
11 11 11 10 11 23 23 22 26 25 24
Total Liabilities & Shareholders' Equity
306 308 306 282 269 278 256 280 304 305 302
Total Liabilities
102 164 150 141 115 149 135 188 202 184 183
Total Current Liabilities
51 68 81 80 79 89 94 143 119 126 127
Accounts Payable
19 17 14 16 5.57 8.62 7.12 12 4.72 17 12
Accrued Expenses
6.48 11 12 14 16 17 19 38 34 30 37
Current Deferred Revenue
24 39 53 49 56 62 65 72 78 75 74
Other Current Liabilities
1.12 1.13 1.66 1.71 1.75 2.19 2.42 21 2.77 3.12 3.12
Total Noncurrent Liabilities
51 96 70 61 36 60 41 45 83 58 56
Long-Term Debt
0.00 0.00 0.00 - - - - - 29 29 29
Noncurrent Deferred Revenue
21 21 19 23 24 24 20 19 18 17 18
Other Noncurrent Operating Liabilities
30 75 50 38 12 36 21 26 36 12 9.80
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
204 144 156 142 153 129 121 93 102 121 119
Total Preferred & Common Equity
204 144 156 142 153 129 121 93 102 121 119
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
204 144 156 142 153 129 121 93 102 121 119
Common Stock
425 432 438 452 460 468 477 490 501 514 521
Retained Earnings
-221 -288 -282 -310 -307 -339 -356 -397 -399 -393 -402
Accumulated Other Comprehensive Income / (Loss)
-0.03 -0.04 -0.01 -0.05 -0.04 -0.13 -0.08 -0.16 -0.14 -0.11 -0.11

Annual Metrics And Ratios for NewHold Investment Corp. II

This table displays calculated financial ratios and metrics derived from NewHold Investment Corp. II's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - 174,617,589.00
DEI Adjusted Shares Outstanding
- - - - - 174,617,589.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.19
Growth Metrics
- - - - - -
Profitability Metrics
- - - - - -
Net Operating Profit after Tax (NOPAT)
-19 -39 -72 -62 -58 -34
Return On Investment Capital (ROIC_SIMPLE)
- - - - -48.97% -22.92%
Earnings before Interest and Taxes (EBIT)
-27 7.87 -89 -111 -57 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-26 11 -83 -102 -39 -8.67
Valuation Ratios
- - - - - -
Leverage & Solvency
- - - - - -
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -27 -106 -62 -98 -47
Efficiency Ratios
- - - - - -
Capital & Investment Metrics
- - - - - -
Invested Capital
3.99 -7.67 27 28 66 79
Increase / (Decrease) in Invested Capital
0.00 -12 35 0.71 40 13
Book Value per Share
($0.52) $2.04 $1.57 $0.97 $0.75 $0.68
Tangible Book Value per Share
($0.52) $2.04 $1.57 $0.97 $0.75 $0.68
Total Capital
7.50 300 257 146 118 148
Total Debt
16 9.95 30 0.00 0.00 29
Total Long-Term Debt
16 7.95 20 0.00 0.00 29
Net Debt
12 -298 -200 -119 -52 -40
Capital Expenditures (CapEx)
6.61 18 24 72 37 37
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-7.56 0.90 14 -25 -27 -41
Debt-free Net Working Capital (DFNWC)
-2.85 309 243 94 25 28
Net Working Capital (NWC)
-2.85 307 233 94 25 28
Net Nonoperating Expense (NNE)
8.56 -28 15 44 -3.60 -0.79
Net Nonoperating Obligations (NNO)
13 -298 -200 -119 -52 -40
Total Depreciation and Amortization (D&A)
1.07 2.90 5.47 9.36 18 24
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.15) $0.00 ($0.71) ($0.34) ($0.20)
Adjusted Weighted Average Basic Shares Outstanding
0.00 71.66M 0.00 149.17M 156.57M 168.42M
Adjusted Diluted Earnings per Share
$0.00 ($0.15) $0.00 ($0.71) ($0.34) ($0.20)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 71.66M 0.00 149.17M 156.57M 168.42M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 143.30M 0.00 152.18M 0.00 179.35M
Normalized Net Operating Profit after Tax (NOPAT)
-19 -37 -71 -62 -57 -32
Debt Service Ratios
- - - - - -
Payout Ratios
- - - - - -

Quarterly Metrics And Ratios for NewHold Investment Corp. II

This table displays calculated financial ratios and metrics derived from NewHold Investment Corp. II's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - 157,550,036.00 - - - 174,617,589.00 179,350,739.00 179,871,410.00
DEI Adjusted Shares Outstanding
- - - - 157,550,036.00 - - - 174,617,589.00 179,350,739.00 179,871,410.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.10 - - - 0.06 -0.03 -0.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.48% 16.61% 28.83% 37.07% - 44.30% 29.02% 56.62% - 44.74% 34.44%
EBITDA Growth
44.87% 65.79% 110.11% -581.99% - 141.23% -627.51% 118.57% - -26.07% 96.13%
EBIT Growth
37.68% 54.99% 104.05% -1,054.56% - 83.70% -1,589.22% 95.11% - -128.35% 78.36%
NOPAT Growth
18.30% 0.95% -35.00% 36.74% - 34.31% 45.26% 55.12% - 41.12% 39.68%
Net Income Growth
40.33% 59.30% 105.19% -703.31% - 85.02% -1,285.93% 94.10% - -196.57% 77.06%
EPS Growth
52.63% 60.00% 104.44% -733.33% - 85.71% -1,350.00% 94.74% - -200.00% 80.00%
Operating Cash Flow Growth
40.78% -368.35% -311.18% 86.22% - 84.28% 109.79% -4.11% - -25.21% 463.28%
Free Cash Flow Firm Growth
69.91% -148.19% -673.20% -5,763.36% - 31.15% 121.82% 88.82% - 77.68% -225.27%
Invested Capital Growth
2.65% 172.72% 880.50% 354.17% - 44.42% -42.34% 2.50% - 2.59% 51.20%
Revenue Q/Q Growth
8.07% -0.70% 17.87% 7.13% - 0.00% 1.68% 31.67% - 20.32% -5.56%
EBITDA Q/Q Growth
-331.33% 41.24% 174.32% -493.76% - 0.00% -1,073.40% 114.05% - -85.07% -151.02%
EBIT Q/Q Growth
-538.90% 31.08% 121.85% -1,217.26% - 0.00% -1,923.83% 96.27% - -140.30% -91.80%
NOPAT Q/Q Growth
24.23% -1.70% -43.17% 39.95% - 0.00% -21.57% 50.86% - 25.73% -24.54%
Net Income Q/Q Growth
-381.55% 31.06% 129.73% -979.35% - 0.00% -2,299.94% 95.57% - -146.03% -85.63%
EPS Q/Q Growth
-400.00% 11.11% 125.00% -1,050.00% - 0.00% -2,400.00% 96.00% - -142.86% -66.67%
Operating Cash Flow Q/Q Growth
-249.88% -411.71% -36.04% 117.85% - 0.00% 183.22% 66.78% - -120.42% 474.39%
Free Cash Flow Firm Q/Q Growth
-832.37% -232.34% -146.26% 46.61% - 0.00% 178.46% -127.34% - 61.64% -340.29%
Invested Capital Q/Q Growth
72.36% 115.89% 62.17% -24.74% - 0.00% -35.25% 33.80% - 11.75% -4.57%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.02% 54.33% 56.66% 57.78% - 59.83% 49.83% 49.72% - 50.94% 50.17%
EBITDA Margin
-70.62% -41.79% 26.35% -96.86% - 11.21% -107.29% 11.45% - 5.72% -3.09%
Operating Margin
-100.39% -102.82% -87.42% -70.00% - -44.96% -53.75% -20.06% - -18.29% -24.11%
EBIT Margin
-84.64% -58.75% 10.89% -113.56% - -6.29% -125.25% -3.54% - -9.93% -20.16%
Profit (Net Income) Margin
-77.40% -53.74% 13.56% -111.27% - -5.28% -124.55% -4.19% - -10.81% -21.25%
Tax Burden Percent
100.30% 100.00% 100.00% 100.00% - 103.87% 100.00% 100.00% - 99.27% 100.00%
Interest Burden Percent
91.17% 91.48% 124.49% 97.98% - 80.73% 99.45% 118.24% - 109.72% 105.41%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Invested Capital (ROIC)
-207.45% -147.62% -185.18% -105.77% - -49.14% -59.78% -26.03% - -23.53% -41.36%
ROIC Less NNEP Spread (ROIC-NNEP)
-206.48% -150.61% -209.39% -88.42% - -63.46% 0.80% -36.09% - -26.27% -36.02%
Return on Net Nonoperating Assets (RNNOA)
176.34% 115.11% 150.05% 60.90% - 28.28% -0.30% 13.11% - 7.33% 12.19%
Return on Equity (ROE)
-31.11% -32.51% -35.13% -44.87% - -20.86% -60.09% -12.93% - -16.21% -29.17%
Cash Return on Invested Capital (CROIC)
-229.42% -244.07% -175.66% -264.31% - -108.25% -10.54% -58.90% - -36.73% -76.38%
Operating Return on Assets (OROA)
-21.05% -16.69% 3.37% -37.19% - -2.66% -55.22% -1.66% - -5.67% -11.87%
Return on Assets (ROA)
-19.25% -15.27% 4.20% -36.43% - -2.23% -54.91% -1.96% - -6.18% -12.51%
Return on Common Equity (ROCE)
-31.11% -32.51% -35.13% -44.87% - -20.86% -60.09% -12.93% - -16.21% -29.17%
Return on Equity Simple (ROE_SIMPLE)
0.00% -63.06% -12.46% -43.69% - -36.70% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-15 -16 -22 -13 -13 -10 -12 -6.02 -7.99 -5.93 -7.39
NOPAT Margin
-70.27% -71.97% -87.42% -49.00% - -31.47% -37.63% -14.04% - -12.80% -16.88%
Net Nonoperating Expense Percent (NNEP)
-0.98% 2.99% 24.22% -17.35% - 14.33% -60.58% 10.05% - 2.73% -5.34%
Return On Investment Capital (ROIC_SIMPLE)
- - - -10.39% -11.23% -8.32% -13.22% -4.60% -5.39% -3.97% -5.00%
Cost of Revenue to Revenue
52.98% 45.67% 43.34% 42.22% - 40.17% 50.17% 50.28% - 49.06% 49.83%
SG&A Expenses to Revenue
50.49% 54.64% 55.54% 51.08% - 46.78% 52.97% 29.36% - 29.17% 32.06%
R&D to Revenue
28.70% 28.64% 22.40% 21.24% - 15.19% 14.56% 13.09% - 12.70% 13.21%
Operating Expenses to Revenue
147.41% 157.14% 144.08% 127.78% - 104.79% 103.59% 69.78% - 69.23% 74.29%
Earnings before Interest and Taxes (EBIT)
-18 -13 2.78 -31 -16 -2.01 -41 -1.52 11 -4.60 -8.82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-15 -9.06 6.73 -27 -11 3.59 -35 4.91 18 2.65 -1.35
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.88 4.78 2.60 4.95 - 4.06 11.05 12.69 - 8.99 8.78
Price to Tangible Book Value (P/TBV)
4.88 4.78 2.60 4.95 - 4.06 11.05 12.69 - 8.99 8.78
Price to Revenue (P/Rev)
8.87 8.11 4.46 6.66 - 4.32 8.46 9.51 - 6.77 6.09
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
21.55 10.01 3.54 8.00 - 5.31 17.71 17.04 - 11.93 11.97
Enterprise Value to Revenue (EV/Rev)
7.39 7.14 3.83 6.08 - 4.02 8.15 9.30 - 6.57 5.88
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 42.09
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 - 0.00 152.86 201.54 - 58.39 36.26
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 - 0.00 0.00 0.28 - 0.24 0.24
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 - 0.00 0.00 0.28 - 0.24 0.24
Financial Leverage
-0.85 -0.76 -0.72 -0.69 - -0.45 -0.38 -0.36 - -0.28 -0.34
Leverage Ratio
1.73 1.70 1.94 2.05 - 2.05 2.23 2.52 - 2.32 2.75
Compound Leverage Factor
1.58 1.56 2.41 2.01 - 1.65 2.22 2.98 - 2.54 2.90
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 21.82% - 19.19% 19.47%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 21.82% - 19.19% 19.47%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% - 100.00% 100.00% 78.18% - 80.81% 80.53%
Debt to EBITDA
0.00 0.00 0.00 0.00 - 0.00 0.00 -0.77 - -2.99 1.20
Net Debt to EBITDA
0.00 0.00 0.00 0.00 - 0.00 0.00 0.75 - 3.38 -1.45
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 - 0.00 0.00 -0.77 - -2.99 1.20
Debt to NOPAT
0.00 0.00 0.00 0.00 - 0.00 0.00 -0.69 - -0.96 -1.15
Net Debt to NOPAT
0.00 0.00 0.00 0.00 - 0.00 0.00 0.67 - 1.09 1.39
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 - 0.00 0.00 -0.69 - -0.96 -1.15
Altman Z-Score
1.85 1.76 1.10 1.03 - 0.70 1.20 2.58 - 2.31 2.11
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.14 1.77 1.74 1.50 - 1.10 0.93 1.27 - 1.21 1.18
Quick Ratio
1.72 1.29 1.17 1.02 - 0.74 0.55 0.88 - 0.82 0.81
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-16 -53 -131 -70 -54 -37 29 -7.84 -21 -8.16 -36
Operating Cash Flow to CapEx
-16.89% -74.94% -720.18% 82.80% - -17.77% 51.22% 23.48% - -64.03% 121.30%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 - -36,534.30 0.00 -10.99 - -8.48 -37.21
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 - -2,539.00 0.00 4.94 - -3.30 12.33
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 - -16,825.00 0.00 -16.11 - -8.47 2.17
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.25 0.28 0.31 0.33 - 0.42 0.44 0.47 - 0.57 0.59
Accounts Receivable Turnover
2.95 3.70 2.59 2.96 - 4.02 3.09 3.26 - 4.15 4.21
Inventory Turnover
4.71 4.31 3.50 3.72 - 4.50 3.47 5.05 - 8.79 8.26
Fixed Asset Turnover
1.02 0.88 0.89 0.89 - 0.88 0.99 1.10 - 1.24 1.35
Accounts Payable Turnover
2.62 2.45 3.68 3.99 - 4.18 6.13 9.48 - 6.65 7.15
Days Sales Outstanding (DSO)
123.75 98.75 140.77 123.19 - 90.70 117.98 111.96 - 87.92 86.63
Days Inventory Outstanding (DIO)
77.42 84.79 104.38 98.02 - 81.08 105.34 72.26 - 41.53 44.17
Days Payable Outstanding (DPO)
139.43 148.74 99.30 91.53 - 87.38 59.54 38.49 - 54.89 51.08
Cash Conversion Cycle (CCC)
61.74 34.80 145.85 129.68 - 84.41 163.78 145.72 - 74.56 79.72
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28 60 97 73 66 86 56 75 79 88 84
Invested Capital Turnover
2.95 2.05 2.12 2.16 - 1.56 1.59 1.85 - 1.84 2.45
Increase / (Decrease) in Invested Capital
0.71 38 109 57 40 26 -41 1.82 13 2.23 29
Enterprise Value (EV)
595 596 342 582 - 457 986 1,270 - 1,053 1,009
Market Capitalization
713 677 398 638 - 492 1,023 1,298 - 1,085 1,043
Book Value per Share
$0.97 $0.93 $0.98 $0.82 $0.75 $0.77 $0.57 $0.59 $0.68 $0.67 $0.66
Tangible Book Value per Share
$0.97 $0.93 $0.98 $0.82 $0.75 $0.77 $0.57 $0.59 $0.68 $0.67 $0.66
Total Capital
146 142 153 129 118 121 93 131 148 149 148
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 29 29 29 29
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 29 29 29 29
Net Debt
-119 -81 -56 -56 -52 -35 -37 -28 -40 -32 -35
Capital Expenditures (CapEx)
19 21 3.04 4.72 8.10 14 4.13 15 3.57 4.97 9.81
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-25 -19 2.04 -11 -27 -26 -47 -24 -41 -35 -41
Debt-free Net Working Capital (DFNWC)
94 62 58 45 25 9.37 -9.81 32 28 26 23
Net Working Capital (NWC)
94 62 58 45 25 9.37 -9.81 32 28 26 23
Net Nonoperating Expense (NNE)
1.56 -3.95 -26 17 2.51 -8.38 28 -4.22 -19 -0.92 1.91
Net Nonoperating Obligations (NNO)
-119 -82 -56 -56 -52 -35 -37 -28 -40 -32 -35
Total Depreciation and Amortization (D&A)
3.06 3.67 3.95 4.57 5.63 5.60 5.84 6.42 6.35 7.25 7.47
Debt-free, Cash-free Net Working Capital to Revenue
-31.00% -22.91% 2.28% -11.84% - -22.56% -38.63% -17.53% - -21.82% -23.80%
Debt-free Net Working Capital to Revenue
116.64% 74.10% 65.56% 46.91% - 8.24% -8.10% 23.66% - 16.30% 13.16%
Net Working Capital to Revenue
116.64% 74.10% 65.56% 46.91% - 8.24% -8.10% 23.66% - 16.30% 13.16%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.10) ($0.08) $0.02 ($0.19) ($0.10) ($0.01) ($0.25) ($0.01) $0.07 ($0.03) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding
149.17M 153.08M 156.47M 157.71M 156.57M 160.81M 165.25M 172.79M 168.42M 177.06M 180.10M
Adjusted Diluted Earnings per Share
($0.09) ($0.08) $0.02 ($0.19) ($0.10) ($0.01) ($0.25) ($0.01) $0.07 ($0.03) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
149.17M 153.08M 171.56M 157.71M 156.57M 160.81M 165.25M 172.79M 168.42M 177.06M 180.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
152.18M 156.09M 157.55M 0.00 0.00 164.00M 171.89M 174.62M 179.35M 179.87M 181.13M
Normalized Net Operating Profit after Tax (NOPAT)
-15 -16 -16 -13 -13 -8.21 -12 -6.02 -5.59 -5.93 -7.39
Normalized NOPAT Margin
-70.27% -71.97% -61.19% -48.47% - -25.65% -37.63% -14.04% - -12.80% -16.88%
Pre Tax Income Margin
-77.17% -53.74% 13.56% -111.27% - -5.08% -124.56% -4.19% - -10.89% -21.25%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 - -2,014.00 0.00 -2.13 - -4.78 -9.14
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 - -10,072.30 0.00 -8.44 - -6.16 -7.65
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 - -16,300.00 0.00 -23.18 - -9.94 -19.31
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 - -24,358.30 0.00 -29.49 - -11.33 -17.82
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Evolv Technologies’ first quarter of 2026 showed a clear revenue rebound, but the company remained deeply unprofitable. Revenue rose to $46.3 million, up from $38.5 million in Q4 2025 and $32.0 million in Q1 2025. Even so, the company posted a net loss of $5.0 million and an operating loss of $8.5 million, so the top-line improvement has not yet translated into sustained profitability.

From a cash perspective, the quarter was stronger than the income statement suggests. Evolv generated negative operating cash flow of $3.2 million, but investing activities contributed $9.8 million of net inflow, helped by $14.7 million in investment sales versus $5.0 million of equipment spending. The result was a $6.9 million increase in cash and equivalents during the quarter.

The balance sheet remains the company’s biggest support. At quarter-end, Evolv held $56.1 million in cash and equivalents plus $5.0 million in short-term investments, against $183.9 million in total liabilities. Total equity was still positive at $120.7 million, giving the company some financial flexibility despite ongoing losses.

  • Revenue accelerated to $46.3 million in Q1 2026 from $38.5 million in Q4 2025 and $32.0 million in Q1 2025, showing continued demand growth.
  • Gross profit improved to $23.6 million, with gross margin around 50.9%, up from roughly 48.4% in Q1 2025.
  • Cash and equivalents were strong at $56.1 million, with another $5.0 million in short-term investments.
  • Quarter-end cash increased by $6.9 million, suggesting the company is not burning cash as quickly as its earnings loss implies.
  • Deferred revenue remained large at $75.3 million current and $17.0 million noncurrent, which may support future recognized revenue.
  • Operating expenses stayed elevated, with SG&A, marketing, and R&D totaling $31.9 million, keeping the company loss-making.
  • Other income was important in reducing the pretax loss, but this is not a dependable recurring source of earnings power.
  • Share count remained high at 177.1 million weighted average shares, limiting per-share earnings progress.
  • Operating cash flow was negative at $3.2 million, showing the core business still does not self-fund operations.
  • Net loss widened again versus the prior quarter from a $1.8 million loss in Q3 2025 to a $5.0 million loss in Q1 2026.

Looking at the multi-year trend, Evolv has made progress on revenue growth, but profitability has been inconsistent. Quarterly revenue has risen from about $18.6 million in Q1 2023 to $46.3 million in Q1 2026, which is a meaningful improvement. However, the company has also posted large losses in many periods, including especially weak quarters in 2023 and 2025, suggesting the business is still working toward a durable operating model.

Investors should watch three things going forward: whether revenue can keep growing, whether operating expenses can be controlled, and whether the company can convert its cash balance and deferred revenue into sustained operating profitability. For now, Evolv looks financially liquid, but it is still very much a turnaround story.

08/17/26 11:32 PM ETAI Generated. May Contain Errors.

NewHold Investment Corp. II Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NewHold Investment Corp. II's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

NewHold Investment Corp. II's net income appears to be on an upward trend, with a most recent value of -$33.14 million in 2025, rising from -$27.39 million in 2020. The previous period was -$54.02 million in 2024.

NewHold Investment Corp. II's total operating income in 2025 was -$48.46 million, based on the following breakdown:
  • Total Gross Profit: $75.30 million
  • Total Operating Expenses: $123.77 million

Over the last 5 years, NewHold Investment Corp. II's total revenue changed from $4.79 million in 2020 to $145.91 million in 2025, a change of 2,949.2%.

NewHold Investment Corp. II's total liabilities were at $184.99 million at the end of 2025, a 23.0% increase from 2024, and a 502.7% increase since 2020.

In the past 5 years, NewHold Investment Corp. II's cash and equivalents has ranged from $4.70 million in 2020 to $307.49 million in 2021, and is currently $49.15 million as of their latest financial filing in 2025.

Over the last 5 years, NewHold Investment Corp. II's book value per share changed from -0.52 in 2020 to 0.68 in 2025, a change of -232.1%.



Financial statements for OTCMKTS:NHICU last updated on 8/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners